insights_auto
Why is SABS down 3,90%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
2,96 USD
arrow_downward
-3,90%(-0,12) 1D
13-ноя., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
3,08 USD
High
3,15 USD
Low
2,85 USD
Mkt. cap
266,66 млн
Avg. vol.
700,24 миң
Volume
658,12 миң
52-wk high
5,15 USD
52-wk low
2,44 USD
EPS
-0,93 USD
Beta
0,67
Shares outstanding
90,09 млн
No. of employees
86
Open
3,08 USD
High
3,15 USD
Low
2,85 USD
Mkt. cap
266,66 млн
Avg. vol.
700,24 миң
Volume
658,12 миң
52-wk high
5,15 USD
52-wk low
2,44 USD
EPS
-0,93 USD
Beta
0,67
Shares outstanding
90,09 млн
No. of employees
86
News stories
From web sources and news partners
TradingKey
·
3 саат мурун
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
TradingView
·
10 саат мурун
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
24/7 Wall St.
·
6 саат мурун
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Traders Union
·
10 саат мурун
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersМайами Бич, Флорида, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websitesab.bio